{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:59:35Z","timestamp":1790675975905,"version":"4.1.0"},"reference-count":17,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5,1]]},"DOI":"10.1210\/jc.2012-3971","type":"journal-article","created":{"date-parts":[[2013,3,29]],"date-time":"2013-03-29T01:43:12Z","timestamp":1364521392000},"page":"2100-2105","source":"Crossref","is-referenced-by-count":107,"title":["Elevated 1-Hour Postload Plasma Glucose Levels Identify Subjects With Normal Glucose Tolerance but Impaired \u03b2-Cell Function, Insulin Resistance, and Worse Cardiovascular Risk Profile: The GENFIEV Study"],"prefix":"10.1210","volume":"98","author":[{"given":"Cristina","family":"Bianchi","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Medicine (C.B., R.M., S.D.P.), Section of Diabetes and Metabolic Diseases, University of Pisa, 56124 Pisa, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Miccoli","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine (C.B., R.M., S.D.P.), Section of Diabetes and Metabolic Diseases, University of Pisa, 56124 Pisa, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Trombetta","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Surgical Sciences (M.T., R.C.B.), Section of Endocrinology and Metabolic Diseases, University of Verona, 37134 Verona, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Giorgino","sequence":"additional","affiliation":[{"name":"Department of Emergency and Organ Transplantation (F.G.), Section on Internal Medicine, Endocrinology and Metabolic Diseases, University of Bari, 70124 Bari, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Frontoni","sequence":"additional","affiliation":[{"name":"Diabetes Center (S.F.), Department of Internal Medicine, University of Rome Tor Vergata, 00133 Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Faloia","sequence":"additional","affiliation":[{"name":"Division of Endocrinology (E.F.), Polytechnic University of Marche, 60121 Ancona, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Marchesini","sequence":"additional","affiliation":[{"name":"Clinical Dietetics (G.M.), Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Dolci","sequence":"additional","affiliation":[{"name":"Section of Diabetes and Metabolic Diseases (M.A.D.), Ss Giacomo e Cristoforo Hospital, 54100 Massa, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Cavalot","sequence":"additional","affiliation":[{"name":"Diabetes Unit (F.C.), Department of Clinical Biological Sciences, University of Turin, 10043 Turin, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisella","family":"Cavallo","sequence":"additional","affiliation":[{"name":"Department of Clinic and Medical Therapy (G.C.), \u201d 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frida","family":"Leonetti","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences (F.L.), University of Rome \u201cLa Sapienza,\u201d 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo C.","family":"Bonadonna","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Surgical Sciences (M.T., R.C.B.), Section of Endocrinology and Metabolic Diseases, University of Verona, 37134 Verona, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Del Prato","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine (C.B., R.M., S.D.P.), Section of Diabetes and Metabolic Diseases, University of Pisa, 56124 Pisa, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the GENFIEV Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113230666700_B1","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1046\/j.1464-5491.2002.00835.x","article-title":"Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention","volume":"19","author":"Unwin","year":"2002","journal-title":"Diabet Med"},{"key":"key\n\t\t\t\t2019041113230666700_B2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Diabetes Prevention Research Group","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113230666700_B3","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113230666700_B4","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc10-S062","article-title":"Diagnosis and classification of diabetes mellitus","volume":"33","author":"American Diabetes Association","year":"2010","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113230666700_B5","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2337\/dc06-1331","article-title":"What is the best predictor of future type 2 diabetes?","volume":"30","author":"Abdul-Ghani","year":"2007","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113230666700_B6","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.2337\/dc08-0225","article-title":"One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes","volume":"31","author":"Abdul-Ghani","year":"2008","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113230666700_B7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2337\/dc08-1264","article-title":"Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study","volume":"32","author":"Abdul-Ghani","year":"2009","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113230666700_B8","doi-asserted-by":"crossref","first-page":"868","DOI":"10.2337\/dc11-2181","article-title":"Insulin sensitivity, \u03b2-cell function, and incretin effect in individuals with elevated 1-hour postload plasma glucose levels","volume":"35","author":"Marini","year":"2012","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113230666700_B9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.atherosclerosis.2009.04.006","article-title":"Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis","volume":"207","author":"Succurro","year":"2009","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t2019041113230666700_B10","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.2337\/dc11-2504","article-title":"Pathogenetic mechanisms and cardiovascular risk: differences between HbA1c and oral glucose tolerance test for the diagnosis of glucose tolerance","volume":"35","author":"Bianchi","year":"2012","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113230666700_B11","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","article-title":"Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","volume":"20","author":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","year":"1997","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113230666700_B12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041113230666700_B13","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.1210\/jc.2010-1041","article-title":"Piragliatin (RO4389620), a novel glucokinase activator, lowers plasma glucose both in the postabsorptive state and after a glucose challenge in patients with type 2 diabetes mellitus: a mechanistic study","volume":"95","author":"Bonadonna","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113230666700_B14","article-title":"PPARG2 Pro12Ala and ADAMTS9 rs4607103 as \u201cinsulin resistance loci\u201d and \u201cinsulin secretion loci\u201d in Italian individuals. The GENFIEV study and the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 4 [published online ahead of print November 17, 2012]","author":"Trombetta","journal-title":"Acta Diabetol"},{"key":"key\n\t\t\t\t2019041113230666700_B15","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.2337\/dc09-2261","article-title":"One-hour plasma glucose identifies insulin resistance and \u03b2-cell dysfunction in individuals with normal glucose tolerance: cross-sectional data from the Relationship between Insulin Sensitivity and Cardiovascular Risk (RISC) study","volume":"33","author":"Manco","year":"2010","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113230666700_B16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00125-003-1263-9","article-title":"\u03b2-Cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study","volume":"47","author":"Gastaldelli","year":"2004","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041113230666700_B17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1055\/s-0028-1087203","article-title":"Tools for predicting the risk of type 2 diabetes in daily practice","volume":"41","author":"Schwarz","year":"2009","journal-title":"Horm Metab Res"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/98\/5\/2100\/9048270\/jcem2100.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T10:27:25Z","timestamp":1562840845000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/98\/5\/2100\/2537068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,1]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2012-3971","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,1]]}}}